Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Goiter × Head & Neck × Clear all

Phase

Phase NA 10 Phase 4 4 Phase 2 2 Phase 3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Head and Neck Neoplasms 151 Squamous Cell Carcinoma of Head and Neck 123 Nasopharyngeal Carcinoma 118 Thyroid Neoplasms 22 Oropharyngeal Neoplasms 22 Mouth Neoplasms 19 Nasopharyngeal Neoplasms 17 Neoplasms 15 Laryngeal Neoplasms 13 Carcinoma, Squamous Cell 13 Hypopharyngeal Neoplasms 11 Carcinoma 11 Salivary Gland Neoplasms 10 Recurrence 10 Radiation Injuries 10 Stomatitis 9 Laryngeal Diseases 8 Parkinson Disease 4, Autosomal Dominant Lewy Body 7 Neoplasm Metastasis 7 Uterine Cervical Neoplasms 6 Tongue Neoplasms 6 Mucositis 6 Esthesioneuroblastoma, Olfactory 6 Breast Neoplasms 6 Xerostomia 5 Pain 5 Thyroid Cancer, Papillary 4 Parathyroid Neoplasms 4 Melanoma 4 Esophageal Neoplasms 4

Interventions

Ropivacaine 1 Epinephrine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02112370 2017-08-04

REBT

Seoul National University Hospital

Phase 3 Completed

148 enrolled 17 charts

Goiter, Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡